UsAgainstAlzheimer’s Statement on Passage of the Advanced Research Projects Agency for Health (ARPA-H) Act (H.R. 5585)

Washington, DC (June 22, 2022)— Today, UsAgainstAlzheimer’s issued the following statement applauding the U.S. House of Representatives passage of the Advanced Research Projects Agency for Health (ARPA-H) Act (H.R. 5585), which includes key provisions to set the new agency up for success:

“The Alzheimer’s community is thrilled with the continuing progress made to get ARPA-H up and running as effectively as possible. By applying the lessons learned from the incredible successes DARPA and ARPA-E have achieved, ARPA-H has the potential to dramatically impact the effort to prevent, diagnose, treat, and cure diseases that rob Americans and populations around the globe of hope, independence, and time. It is heartening to see the process of getting it set up continue expediently. 

“We applaud Chairwoman Eshoo’s leadership on both this bill and the broader fight against Alzheimer’s. We have had the honor of working closely with Rep. Eshoo on this effort and were pleased to see that it includes the key provisions needed to set ARPA-H up for success in its mission to advance health innovation for all Americans. We also thank Chairman Pallone, Ranking Member McMorris Rodgers, Health Subcommittee Ranking Member Guthrie, and other members of the Energy & Commerce Committee for their bipartisan efforts to refine and advance this bill.

“We also stand ready to work with the Senate in their effort to pass their own version of this bill and are encouraged by the work of Chairwoman Murray and Ranking Member Burr on this front. The sooner ARPA-H can reach its full potential, the sooner families and individuals living with Alzheimer’s will get relief from this devastating disease.”

###
About UsAgainstAlzheimer’s
UsAgainstAlzheimer’s exists to conquer Alzheimer’s disease. We take on the toughest problems; bring all of “Us” together to break down barriers; advocate for research that will speed treatments to market; and drive changes that matter most to people living with the disease. We will not rest until brain-span equals lifespan - for everyone.